TDTony Duong

Tony Duong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tony Duong has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Canan Schumann

    Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, USA

    2 shared publications
  • Oleh Taratula

    Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, 2730 SW Moody Avenue, Portland, Oregon, 97201, USA

    2 shared publications
  • Bona Yang

    Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, USA

    1 shared publication
  • Hassan A Albarqi

    Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, USA

    1 shared publication
  • Karmin L. Taylor

    Department of Pharmaceutical Sciences

    1 shared publication
  • Xiaoning Li

    Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, USA

    1 shared publication

Latest Publications

  • Phototheranostic nanoplatform based on a single cyanine dye for image-guided combinatorial phototherapy

    by Tony Duong, Xiaoning Li, Bona Yang, Canan Schumann, Hassan A Albarqi, Olena Taratula, Oleh Taratula


  • Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy

    by Olena Taratula, Canan Schumann, Tony Duong, Karmin L. Taylor

    Multifunctional theranostic platforms capable of concurrent near-infrared (NIR) fluorescence imaging and phototherapies are strongly desired for cancer diagnosis and treatment. However, the integration of separate imaging and therapeutic components into nanocarriers results in complex theranostic systems with limited translational potential. A single agent-based theranostic nanoplatform, therefore, was developed for concurrent NIR fluorescence imaging and combinatorial phototherapy with dual photodynamic (PDT) and photothermal (PTT) therapeutic mechanisms. The transformation of a substituted silicon naphthalocyanine (SiNc) into a biocompatible nanoplatform (SiNc-NP) was achieved by SiNc encapsulation into the hydrophobic interior of a generation 5 polypropylenimine dendrimer following surface modification with polyethylene glycol. Encapsulation provides aqueous solubility to SiNc and preserves its NIR fluorescence, PDT and PTT properties. Moreover, an impressive photostability in the dendrimer-encapsulated SiNc has been detected. Under NIR irradiation (785 nm, 1.3 W cm−2), SiNc-NP manifested robust heat generation capability (ΔT = 40 °C) and efficiently produced reactive oxygen species essential for PTT and PDT, respectively, without releasing SiNc from the nanopaltform. By varying the laser power density from 0.3 W cm−2 to 1.3 W cm−2 the therapeutic mechanism of SiNc-NP could be switched from PDT to combinatorial PDT–PTT treatment. In vitro and in vivo studies confirmed that phototherapy mediated by SiNc can efficiently destroy chemotherapy resistant ovarian cancer cells. Remarkably, solid tumors treated with a single dose of SiNc-NP combined with NIR irradiation were completely eradicated without cancer recurrence. Finally, the efficiency of SiNc-NP as an NIR imaging agent was confirmed by recording the strong fluorescence signal in the tumor, which was not photobleached during the phototherapeutic procedure.